Daiichi Sankyo Company is a global pharmaceutical company based in Japan. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, it focuses on research and development of innovative medicines, particularly in the fields of oncology, cardiovascular diseases, and vaccines. The company operates in over 20 countries and aims to improve patient health worldwide. The company is known for its commitment to scientific advancement and collaboration. Daiichi Sankyo invests significantly in research and development, working with various partners to discover new treatments. Its dedication to quality and innovation has established it as a key player in the global pharmaceutical industry.